Liarozole

Drug Profile

Liarozole

Alternative Names: Liazal; R 75251; R 85246

Latest Information Update: 19 Jul 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Janssen Pharmaceutica
  • Class Antineoplastics; Antipsoriatics; Imidazoles; Small molecules
  • Mechanism of Action Aromatase inhibitors; Cytochrome P 450 enzyme system inhibitors; Retinoic acid metabolism modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ichthyosis

Highest Development Phases

  • Discontinued Bladder cancer; Breast cancer; Ichthyosis; Prostate cancer; Psoriasis

Most Recent Events

  • 20 Jan 2006 Phase-II/III clinical trials in Ichthyosis in Canada (PO)
  • 20 Jan 2006 Phase-II/III clinical trials in Ichthyosis in Europe (PO)
  • 18 Aug 2005 Clinical development is ongoing for Ichthyosis in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top